The Prague Post - Who should get paid for nature's sequenced genes?

EUR -
AED 4.114065
AFN 72.259582
ALL 90.790621
AMD 404.158249
ANG 2.004979
AOA 1027.255243
ARS 1706.277137
AUD 1.593279
AWG 2.019222
AZN 1.908846
BAM 1.955598
BBD 2.254667
BDT 138.445698
BGN 1.95798
BHD 0.422456
BIF 3355.553362
BMD 1.120234
BND 1.430852
BOB 13.181638
BRL 5.562192
BSD 1.119484
BTN 106.219027
BWP 15.421407
BYN 3.28696
BYR 21956.591821
BZD 2.251367
CAD 1.568609
CDF 2594.46299
CHF 0.92428
CLF 0.028335
CLP 1115.204868
CNY 7.480981
CNH 7.472639
COP 3529.197267
CRC 510.847228
CUC 1.120234
CUP 26.866225
CVE 110.25361
CZK 24.330933
DJF 199.339408
DKK 7.473811
DOP 68.662907
DZD 150.487454
EGP 61.701626
ERN 16.803514
ETB 182.080891
FJD 2.506193
FKP 0.837532
GBP 0.83759
GEL 2.901844
GGP 0.837532
GHS 12.979659
GIP 0.837532
GMD 82.897735
GNF 9906.976581
GTQ 8.557116
GYD 234.45578
HKD 8.78527
HNL 30.053895
HRK 7.537165
HTG 146.714844
HUF 366.731529
IDR 20269.350965
ILS 3.478944
IMP 0.837532
INR 106.361208
IQD 1697.024692
IRR 2052689.282929
ISK 136.422562
JEP 0.837532
JMD 177.661647
JOD 0.79429
JPY 175.72038
KES 145.354984
KGS 97.962924
KHR 4573.527541
KMF 492.347215
KPW 1008.210806
KRW 1482.658115
KWD 0.348046
KYD 0.932904
KZT 508.267495
LAK 25190.397759
LBP 100245.344367
LKR 371.711601
LRD 190.860284
LSL 18.546684
LTL 3.307761
LVL 0.677619
LYD 7.169259
MAD 10.995664
MDL 20.205913
MGA 5062.477032
MKD 61.598637
MMK 2352.70217
MNT 4032.758987
MOP 9.043866
MRU 44.738378
MUR 52.830672
MVR 17.319246
MWK 1941.099479
MXN 20.912986
MYR 4.576498
MZN 71.587148
NAD 18.546684
NGN 1492.219693
NIO 41.195744
NOK 10.482469
NPR 169.950444
NZD 1.961367
OMR 0.429016
PAB 1.119384
PEN 3.844503
PGK 5.013482
PHP 71.267107
PKR 309.775499
PLN 4.40251
PYG 6474.331183
QAR 4.080578
RON 5.3545
RSD 117.984237
RUB 89.990404
RWF 1653.929144
SAR 4.202624
SBD 9.045421
SCR 15.663382
SDG 673.825035
SEK 11.125947
SGD 1.430432
SHP 0.837151
SLE 25.709792
SLL 23490.757589
SOS 639.733914
SRD 42.152218
STD 23186.587781
STN 24.497469
SVC 9.794988
SYP 14565.285711
SZL 18.546084
THB 37.830725
TJS 10.315634
TMT 3.932022
TND 3.342755
TOP 2.697255
TRY 55.679905
TTD 7.606214
TWD 36.503734
TZS 2963.693842
UAH 50.679165
UGX 4931.490563
USD 1.120234
UYU 44.895362
UZS 13396.616091
VES 985.569686
VND 28949.654292
VUV 133.391269
WST 3.100456
XAF 655.957
XAG 0.020782
XAU 0.000280356799
XCD 3.02749
XCG 2.017492
XDR 0.792064
XOF 655.957
XPF 119.331742
YER 264.491333
ZAR 18.566461
ZMK 10083.456786
ZMW 22.506675
ZWL 360.71498
SSP 6436.51929
MXV 2.360302
  • BCC

    -0.5500

    77.74

    -0.71%

  • NGG

    -0.7800

    81.86

    -0.95%

  • GSK

    -0.4600

    50.75

    -0.91%

  • RIO

    -0.7200

    83.42

    -0.86%

  • BTI

    -0.9900

    59.48

    -1.66%

  • RBGPF

    2.6200

    72.77

    +3.6%

  • BCE

    -0.4100

    20.4

    -2.01%

  • CMSC

    0.0000

    19.6

    0%

  • RELX

    -0.0800

    40.54

    -0.2%

  • CMSD

    0.1800

    19.78

    +0.91%

  • JRI

    0.0700

    10.75

    +0.65%

  • VOD

    -0.3800

    15.74

    -2.41%

  • AZN

    -1.0800

    171.49

    -0.63%

  • BP

    1.2700

    51.32

    +2.47%

  • RYCEF

    -1.7500

    15.26

    -11.47%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Kolar--TPP